Circulating dipeptidyl peptidase-4 activity correlates with measures of hepatocyte apoptosis and fibrosis in non-alcoholic fatty liver disease in type 2 diabetes mellitus and obesity: A dual cohort cross-sectional study

Hepatic apoptosis can modulate liver fibrosis through TIMP1 pathway

(2013) Kewei Wang et al.   APOPTOSIS

Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types

(2013) X. Ou et al.   BLOOD

Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study

(2013) J. D. Price et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Diabetes and Nonalcoholic Fatty Liver Disease: A Pathogenic Duo

(2013) K. H. Williams et al.   ENDOCRINE REVIEWS

CD26/DPP4 Levels in Peripheral Blood and T Cells in Patients With Type 2 Diabetes Mellitus

(2013) Sang Ah Lee et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effects of Sitagliptin on Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Rats

(2013) Selvihan Beysel Akaslan et al.   Metabolic Syndrome and Related Disorders

Dipeptidyl peptidase-4: A key player in chronic liver disease

(2013) Minoru Itou   WORLD JOURNAL OF GASTROENTEROLOGY

Quantitation of fibroblast activation protein (FAP)-specific protease activity in mouse, baboon and human fluids and organs

(2013) Fiona M. Keane et al.   FEBS Open Bio

Liver Stiffness Measurement Using XL Probe in Patients With Nonalcoholic Fatty Liver Disease

(2012) Vincent Wai-Sun Wong et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

When GLP-1 hits the liver: a novel approach for insulin resistance and NASH

(2012) Yong Ook Kim et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Association between HbA1c and dipeptidyl peptidase IV activity in type 2 diabetes mellitus

(2012) Luziane Potrich Bellé et al.   CLINICA CHIMICA ACTA

Serum levels of advanced glycation end products (AGEs) are independently correlated with circulating levels of dipeptidyl peptidase-4 (DPP-4) in humans

(2012) Nobuhiro Tahara et al.   CLINICAL BIOCHEMISTRY

Erratum to: Dipeptidyl Peptidase 4-Deficient Rats Have Improved Bile Secretory Function in High Fat Diet-Induced Steatosis

(2012) Shani Ben-Shlomo et al.   DIGESTIVE DISEASES AND SCIENCES

Plasma dipeptidyl peptidase 4 activity correlates with body mass index and the plasma adiponectin concentration in healthy young people

(2012) Yasushi Kirino et al.   ENDOCRINE JOURNAL

Dipeptidylpeptidase-­IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats

(2012) E. Tarantola et al.   EUROPEAN JOURNAL OF HISTOCHEMISTRY

Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice

(2011) J. Shirakawa et al.   DIABETES

The increased dipeptidyl peptidase-4 activity is not counteracted by optimized glucose control in type 2 diabetes, but is lower in metformin-treated patients

(2011) G. P. Fadini et al.   DIABETES OBESITY & METABOLISM

Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus

(2011) Tomoyuki Iwasaki et al.   HEPATO-GASTROENTEROLOGY

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients

(2011) Robert P. Myers et al.   HEPATOLOGY

Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis

(2011) Gianluca Svegliati-Baroni et al.   LIVER INTERNATIONAL

Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?

(2011) Mariana Verdelho Machado et al.   Expert Review of Gastroenterology & Hepatology

Altered dipeptidyl peptidase-4 activity during the progression of hyperinsulinemic obesity and islet atrophy in spontaneously late-stage type 2 diabetic rats

(2010) Yasushi Kirino et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

(2010) Giovanni Musso et al.   ANNALS OF MEDICINE

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

(2010) Elizabeth M. Brunt et al.   HEPATOLOGY

Role of dipeptidyl peptidase IV (DPP4) in the development of dyslipidemia: DPP4 contributes to the steroid metabolism pathway

(2010) Youichi Sato et al.   LIFE SCIENCES

Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker

(2010) Gábor Firneisz et al.   PLoS One

Soluble CD26 / Dipeptidyl Peptidase IV Enhances Human Lymphocyte Proliferation In Vitro Independent of Dipeptidyl Peptidase Enzyme Activity and Adenosine Deaminase Binding

(2010) D. M. T. Yu et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis

(2009) Rafal P. Witek et al.   HEPATOLOGY

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study

(2009) Ariel E. Feldstein et al.   HEPATOLOGY

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

(2009) Vincent Wai-Sun Wong et al.   HEPATOLOGY